Literature DB >> 24512418

Discovery of biomarkers for chronic graft-versus-host disease.

Dario Costa1, Rossella Paolillo, Amelia Casamassimi, Claudio Napoli.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24512418      PMCID： PMC3967472          DOI： 10.14503/THIJ-13-3963

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  6 in total

1.  Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.

Authors:  Anna Bosch-Vizcaya; Arianne Pérez-García; Salut Brunet; Carlos Solano; Ismael Buño; Vicent Guillem; Carolina Martínez-Laperche; Guillermo Sanz; Cristina Barrenetxea; Carmen Martínez; Esperanza Tuset; Natàlia Lloveras; Rosa Coll; Ramon Guardia; Yolanda González; Josep M Roncero; Anna Bustins; Santiago Gardella; Cristalina Fernández; Joan Buch; David Gallardo
Journal:  Biol Blood Marrow Transplant       Date:  2011-06-12       Impact factor: 5.742

2.  Elevation of CRP precedes clinical suspicion of bloodstream infections in patients undergoing hematopoietic cell transplantation.

Authors:  Ron Ram; Moshe Yeshurun; Laura Farbman; Corina Herscovici; Ofer Shpilberg; Mical Paul
Journal:  J Infect       Date:  2013-05-23       Impact factor: 6.072

3.  MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease.

Authors:  Wahid Boukouaci; Marc Busson; Régis Peffault de Latour; Vanderson Rocha; Caroline Suberbielle; Djaouida Bengoufa; Nicolas Dulphy; Philippe Haas; Catherine Scieux; Habiba Amroun; Eliane Gluckman; Rajagopal Krishnamoorthy; Antoine Toubert; Dominique Charron; Gérard Socié; Ryad Tamouza
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

4.  Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.

Authors:  Shigeo Fuji; Sung-Won Kim; Takahiro Fukuda; Shin-ichiro Mori; Satoshi Yamasaki; Yuriko Morita-Hoshi; Fusako Ohara-Waki; Yuji Heike; Kensei Tobinai; Ryuji Tanosaki; Yoichi Takaue
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

5.  Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.

Authors:  Priyanka A Pophali; Jeffrey K Klotz; Sawa Ito; Natasha A Jain; Eleftheria Koklanaris; Robert Q Le; Christopher S Hourigan; Bipin N Savani; Kamna Chawla; Sujata Shanbhag; A John Barrett; Minoo Battiwalla
Journal:  Exp Hematol       Date:  2013-10-17       Impact factor: 3.084

6.  Cardiac effects of chronic graft-versus-host disease after stem cell transplantation.

Authors:  Ali Dogan; Orhan Dogdu; Ibrahim Ozdogru; Mikail Yarlioglues; Nihat Kalay; Mehmet Tugrul Inanc; Idris Ardic; Ahmet Celik; Leylagul Kaynar; Fatih Kurnaz; Namik Kemal Eryol; Mehmet Gungor Kaya
Journal:  Tex Heart Inst J       Date:  2013
  6 in total
  1 in total

1.  Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease.

Authors:  Jennifer E Vaughn; Ted Gooley; Richard T Maziarz; Michael A Pulsipher; Smita Bhatia; David G Maloney; Brenda M Sandmaier; Mary E Flowers; Rainer Storb; Mohamed L Sorror
Journal:  Br J Haematol       Date:  2015-07-20       Impact factor: 6.998
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.